No Data
Showa Pharmaceutical - For the fiscal year ending March 2025, there was an increase in revenue and profit, with gross profit achieving the highest figure for four consecutive quarters.
Showa Pharmaceutical Co., Ltd. (3537) announced its consolidated financial results for the fiscal year ending March 2025 on the 12th. Revenue increased by 10.7% year-on-year to 25.012 billion yen, operating profit increased by 27.1% to 0.559 billion yen, ordinary profit increased by 16.2% to 0.757 billion yen, and net income attributable to shareholders of the parent company increased by 7.2% to 0.527 billion yen. The absolute amount of gross profit, which is a management Indicator targeted by the company group, has experienced sustainable growth, as each business unit has worked to improve profit margins and significantly exceeded the originally planned figures.
Showa Pharmaceutical - Introduced a progressive Dividends policy, increasing the year-end Dividends for the fiscal year ending March 2025 by 1 yen.
Shoei Pharmaceutical <3537> announced on the 12th a change in its dividend policy and the distribution of surplus for the fiscal year ending March 2025. A new progressive dividend policy has been introduced, deciding the year-end dividend for the fiscal year ending March 2025 to be 39 yen per share. This represents an increase of 1 yen from the previous financial estimate of 38 yen and the prior year's results of 38 yen. A progressive dividend is a dividend policy that, in principle, maintains or increases dividends without reducing them. This has clarified the policy to strengthen the stable return of profits to shareholders.
Shoei Yakuhin To Go Ex-Dividend On March 30th, 2026 With 39 JPY Dividend Per Share
May 13th (Japan Standard Time) - $Shoei Yakuhin(3537.JP)$ is trading ex-dividend on March 30th, 2026.Shareholders of record on March 31st, 2026 will receive 39 JPY dividend per share. The ex-
Shoei Yakuhin: Notice regarding changes in dividend policy (introduction of progressive dividends) and dividends from surplus (increase in dividends)
Shoei Yakuhin: Summary of financial results for the fiscal year ending March 31, 2025 [Japanese GAAP] (consolidated)
Shionogi, Shiseido Company, Limited Sponsored ADR, ORIX, and Mitsubishi Estate (12th)
※The above Calendar is only a schedule and may be subject to change due to the company's circumstances.---------------------------------------May 12 (Mon) <1301> Kyokuyo <1333> Maruha Nichiro <1420> Sanyo H <1515> Nippon Steel Mining <1736> Aotec <1798> Moriya Shokai <1807> Sato Watanabe <1820> Nishimatsu Construction <1826>
